DK2422766T3 - Tørpulversammensætninger af glycopyrrolat og magnesiumstearat - Google Patents

Tørpulversammensætninger af glycopyrrolat og magnesiumstearat Download PDF

Info

Publication number: DK2422766T3
Authority: DK; Denmark
Prior art keywords: glycopyrrolate; magnesium stearate; dry powder; powder compositions; compositions
Prior art date: 2004-04-30

Application number

DK11190637.6T

Other languages

English (en)

Inventor

David Morton

Martin Shott

Rebecca Davies

Original Assignee

Vectura Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-30

Filing date

2005-04-29

Publication date

2015-08-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32408337&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2422766(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-04-29 Application filed by Vectura Ltd filed Critical Vectura Ltd

2015-08-31 Application granted granted Critical

2015-08-31 Publication of DK2422766T3 publication Critical patent/DK2422766T3/da

Links

HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 title 2
VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical group [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 title 1
229940015042 glycopyrrolate Drugs 0.000 title 1
235000019359 magnesium stearate Nutrition 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000000843 powder Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK11190637.6T 2004-04-30 2005-04-29 Tørpulversammensætninger af glycopyrrolat og magnesiumstearat DK2422766T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0409703.6A GB0409703D0 (en)	2004-04-30	2004-04-30	Pharmaceutical compositions
EP05738040A EP1755555B1 (en)	2004-04-30	2005-04-29	Methods for preparing dry powder compositions of glycopyrrolate

Publications (1)

Publication Number	Publication Date
DK2422766T3 true DK2422766T3 (da)	2015-08-31

Family

ID=32408337

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK05738040.4T DK1755555T3 (da)	2004-04-30	2005-04-29	Fremgangsmåde til fremstilling af tørpulversammensætninger af glycopyrrolat
DK11190637.6T DK2422766T3 (da)	2004-04-30	2005-04-29	Tørpulversammensætninger af glycopyrrolat og magnesiumstearat

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK05738040.4T DK1755555T3 (da)	2004-04-30	2005-04-29	Fremgangsmåde til fremstilling af tørpulversammensætninger af glycopyrrolat

Country Status (26)

Country	Link
US (1)	US20080063719A1 (da)
EP (3)	EP2422766B1 (da)
JP (2)	JP5000483B2 (da)
KR (1)	KR101287919B1 (da)
CN (3)	CN1964700A (da)
AU (2)	AU2005237266B2 (da)
BR (1)	BRPI0510500B8 (da)
CA (1)	CA2563760C (da)
CY (6)	CY1113069T1 (da)
DK (2)	DK1755555T3 (da)
ES (2)	ES2388289T3 (da)
GB (1)	GB0409703D0 (da)
HU (4)	HUE025463T2 (da)
IL (2)	IL178651A (da)
LT (1)	LTC2422766I2 (da)
LU (2)	LU92176I2 (da)
MX (2)	MXPA06012493A (da)
NO (1)	NO20065502L (da)
NZ (1)	NZ550479A (da)
PL (2)	PL1755555T3 (da)
PT (2)	PT2422766E (da)
RU (1)	RU2396943C2 (da)
SG (3)	SG10201605001SA (da)
SI (2)	SI1755555T1 (da)
WO (1)	WO2005105043A2 (da)
ZA (1)	ZA200609350B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0409703D0 (en) *	2004-04-30	2004-06-02	Vectura Ltd	Pharmaceutical compositions
GB0425758D0 (en) *	2004-11-23	2004-12-22	Vectura Ltd	Preparation of pharmaceutical compositions
GB0525254D0 (en) *	2005-12-12	2006-01-18	Jagotec Ag	Powder compositions for inhalation
GB0613161D0 (en)	2006-06-30	2006-08-09	Novartis Ag	Organic Compounds
GB0622818D0 (en) *	2006-11-15	2006-12-27	Jagotec Ag	Improvements in or relating to organic compounds
EP2234595B1 (en) *	2007-12-13	2012-11-28	Novartis AG	Process for reducing the tendency of a glycopyyronium salt to aggegate during storage.
US20100266696A1 (en) *	2007-12-13	2010-10-21	Gerhard Muhrer	Organic Compounds
NZ587561A (en) *	2008-02-26	2012-10-26	Elevation Pharmaceuticals Inc	Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations (an muscarinic antagnoist)
US20100055045A1 (en)	2008-02-26	2010-03-04	William Gerhart	Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
JP5809985B2 (ja)	2009-02-26	2015-11-11	グラクソグループリミテッドＧｌａｘｏＧｒｏｕｐＬｉｍｉｔｅｄ	４−｛（１ｒ）−２−［（６−｛２−［（２，６−ジクロロベンジル）オキシ］エトキシ｝ヘキシル）アミノ］−１−ヒドロキシエチル｝−２−（ヒドロキシメチル）フェノールを含む医薬製剤
CA2759041A1 (en) *	2009-04-24	2010-10-28	Schering Corporation	Agglomerate formulations useful in dry powder inhalers
GB0921075D0 (en)	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
GB0921481D0 (en)	2009-12-08	2010-01-20	Vectura Ltd	Process and product
RU2012138909A (ru) *	2010-03-31	2014-05-10	Гленмарк Фармасьютикалс Лимитед	Фармацевтическая порошковая композиция для ингаляций
RU2585101C2 (ru) *	2010-04-01	2016-05-27	КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.	Способ приготовления частиц носителя для сухих порошков для ингаляции
HUE038555T2 (hu)	2010-04-21	2018-10-29	Chiesi Farm Spa	Eljárás csökkentett elektrosztatikus töltéssel rendelkezõ részecskék elõállítására
AU2011298315B2 (en)	2010-08-31	2014-08-28	Glaxo Group Limited	Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
EP3461474B1 (en)	2010-08-31	2020-11-11	GlaxoSmithKline Intellectual Property Development Limited	Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
JO3510B1 (ar)	2011-03-04	2020-07-05	Heptares Therapeutics Ltd	استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
US9763965B2 (en)	2012-04-13	2017-09-19	Glaxosmithkline Intellectual Property Development Limited	Aggregate particles
AU2013100007B4 (en) *	2013-01-04	2013-05-23	Novartis Ag	System for treating chronic obstructive pulmonary disease
US9006462B2 (en)	2013-02-28	2015-04-14	Dermira, Inc.	Glycopyrrolate salts
ES2699257T3 (es)	2013-02-28	2019-02-08	Dermira Inc	Sales de glicopirrolato
US8558008B2 (en)	2013-02-28	2013-10-15	Dermira, Inc.	Crystalline glycopyrrolate tosylate
US20140275517A1 (en) *	2013-03-15	2014-09-18	Pearl Therapeutics, Inc.	Methods and systems for conditioning of particulate crystalline materials
GB201305825D0 (en) *	2013-03-28	2013-05-15	Vectura Ltd	New use
US9393202B2 (en) *	2013-04-26	2016-07-19	Chiesi Farmaceutici S.P.A	Particle size reduction of an antimuscarinic compound
GB201402556D0 (en)	2014-02-13	2014-04-02	Crystec Ltd	Improvements relating to inhalable particles
SG11201700536XA (en)	2014-09-09	2017-02-27	Vectura Ltd	Formulation comprising glycopyrrolate, method and apparatus
CA2963146A1 (en) *	2014-10-16	2016-04-21	Teva Branded Pharmaceutical Products R&D, Inc.	Dry powder formulation
US9925168B2 (en) *	2016-01-22	2018-03-27	Chiesi Farmaceutici S.P.A.	Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation
CA3016368A1 (en)	2016-03-08	2017-09-14	Mereo Biopharma 1 Limited	Dosage regimen for the treatment of acute exacerbations of inflammatory conditions
KR102762199B1 (ko)	2016-03-08	2025-02-07	메레오 바이오파마 1 리미티드	만성 폐쇄성 폐 질환의 급성 악화 치료를 위한 투약법
US10888500B2 (en)	2016-07-29	2021-01-12	Inke, S.A.	Particle size stabilization process
CN114515284A (zh)	2016-09-19	2022-05-20	墨西哥氟石股份公司	药物组合物
US11219602B2 (en)	2017-03-15	2022-01-11	Vectura Limited	Method for making a micronized dry powder formulation of glycopyrrolate and magnesium stearate
WO2019060604A1 (en) *	2017-09-20	2019-03-28	Teva Branded Pharmaceutical Products R&D, Inc.	INHALABLE MEDICINE
WO2019060595A1 (en)	2017-09-20	2019-03-28	Teva Branded Pharmaceutical Products R&D, Inc.	INHALABLE DRY POWDER MEDICINAL PRODUCT COMPRISING GLYCOPYRRONIUM
PL3585383T3 (pl)	2017-12-11	2021-07-05	Mereo Biopharma 1 Limited	Zastosowanie 3-[5-amino-4-(3-cyjanobenzoilo)pirazol-1-ilo]- n-cyklopropylo- 4-metylobenzamidu w zapobieganiu ostrym zaostrzeniom przewlekłej obturacyjnej choroby płuc
ES2884789T3 (es)	2017-12-11	2021-12-13	Mereo Biopharma 1 Ltd	Uso de 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciclopropil-4-metilbenzamida en el tratamiento de exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica
KR102696616B1 (ko)	2018-12-21	2024-08-20	한미약품 주식회사	흡입 제형용 건조 분말 및 이의 제조방법
US20250058063A1 (en)	2021-12-21	2025-02-20	Chiesi Farmaceutici S.P.A.	Dry powder formulations filled in an inhaler with improved resistance to humidity
CN118414147A (zh)	2021-12-21	2024-07-30	凯西制药公司	填充在具有改善的耐湿性的吸入器中的干粉制剂

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2956062A (en) *	1959-02-26	1960-10-11	Robins Co Inc A H	Esters of amino alcohols
US3709039A (en) *	1970-08-31	1973-01-09	Gen Time Corp	Comfort humidity indicator
SE9302777D0 (sv) *	1993-08-27	1993-08-27	Astra Ab	Process for conditioning substances
GB9501841D0 (en)	1995-01-31	1995-03-22	Co Ordinated Drug Dev	Improvements in and relating to carrier particles for use in dry powder inhalers
US5612053A (en) *	1995-04-07	1997-03-18	Edward Mendell Co., Inc.	Controlled release insufflation carrier for medicaments
GB9808470D0 (en)	1998-04-22	1998-06-17	Smithkline Beecham Plc	Novel process and apparatus
DK1283036T3 (da)	1998-11-13	2008-03-25	Jagotec Ag	Törpulver til inhalation
GB9826284D0 (en) *	1998-12-01	1999-01-20	Rhone Poulence Rorer Limited	Process
GB9826286D0 (en)	1998-12-01	1999-01-20	Rhone Poulence Rorer Limited	Process
GB0008660D0 (en) *	2000-04-07	2000-05-31	Arakis Ltd	The treatment of respiratory diseases
PE20011227A1 (es)	2000-04-17	2002-01-07	Chiesi Farma Spa	Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
PT1913939T (pt)	2000-06-27	2017-07-19	Vectura Ltd	Formulações para utilização em dispositivos inalatórios
AU2211502A (en) *	2000-11-30	2002-06-11	Vectura Ltd	Method of making particles for use in a pharmaceutical composition
PT2283817T (pt)	2000-11-30	2016-08-22	Vectura Ltd	Método de fabrico de partículas para utilização numa composição farmacêutica
ATE375142T1 (de) *	2001-03-30	2007-10-15	Jagotec Ag	Medizinische aerosolformulierungen
JP2005530765A (ja) *	2002-05-07	2005-10-13	ネクターセラピューティクス	乾燥粉末吸入器のためのカプセル及びそれを製造及び使用する方法
GB2405798A (en) *	2003-09-15	2005-03-16	Vectura Ltd	Dry powder inhaler with primary and secondary piercing elements and a medicament pack for use with an inhalation device.
GB0409703D0 (en) *	2004-04-30	2004-06-02	Vectura Ltd	Pharmaceutical compositions
JP2008534480A (ja) *	2005-03-24	2008-08-28	ソーセイアールアンドディリミテッド	グリコピロニウム塩およびそれらの治療的使用

2004
- 2004-04-30 GB GBGB0409703.6A patent/GB0409703D0/en not_active Ceased
2005
- 2005-04-29 CN CNA200580013592XA patent/CN1964700A/zh active Pending
- 2005-04-29 PT PT111906376T patent/PT2422766E/pt unknown
- 2005-04-29 SG SG10201605001SA patent/SG10201605001SA/en unknown
- 2005-04-29 HU HUE11190637A patent/HUE025463T2/en unknown
- 2005-04-29 NZ NZ550479A patent/NZ550479A/en not_active IP Right Cessation
- 2005-04-29 PT PT05738040T patent/PT1755555E/pt unknown
- 2005-04-29 SG SG2012093886A patent/SG186673A1/en unknown
- 2005-04-29 JP JP2007510045A patent/JP5000483B2/ja not_active Expired - Lifetime
- 2005-04-29 PL PL05738040T patent/PL1755555T3/pl unknown
- 2005-04-29 KR KR1020067024763A patent/KR101287919B1/ko not_active Expired - Lifetime
- 2005-04-29 ES ES05738040T patent/ES2388289T3/es not_active Expired - Lifetime
- 2005-04-29 SI SI200531570T patent/SI1755555T1/sl unknown
- 2005-04-29 PL PL11190637T patent/PL2422766T3/pl unknown
- 2005-04-29 US US11/587,725 patent/US20080063719A1/en not_active Abandoned
- 2005-04-29 WO PCT/EP2005/051980 patent/WO2005105043A2/en not_active Ceased
- 2005-04-29 SG SG200903001-6A patent/SG152292A1/en unknown
- 2005-04-29 CN CN201710357916.6A patent/CN107252423A/zh active Pending
- 2005-04-29 SI SI200531999T patent/SI2422766T1/sl unknown
- 2005-04-29 EP EP11190637.6A patent/EP2422766B1/en not_active Revoked
- 2005-04-29 AU AU2005237266A patent/AU2005237266B2/en active Active
- 2005-04-29 MX MXPA06012493A patent/MXPA06012493A/es active IP Right Grant
- 2005-04-29 DK DK05738040.4T patent/DK1755555T3/da active
- 2005-04-29 ES ES11190637.6T patent/ES2546982T3/es not_active Expired - Lifetime
- 2005-04-29 CN CN2010105642463A patent/CN102008453A/zh active Pending
- 2005-04-29 EP EP05738040A patent/EP1755555B1/en not_active Revoked
- 2005-04-29 BR BRPI0510500A patent/BRPI0510500B8/pt not_active IP Right Cessation
- 2005-04-29 DK DK11190637.6T patent/DK2422766T3/da active
- 2005-04-29 EP EP11190638A patent/EP2422767A3/en not_active Withdrawn
- 2005-04-29 RU RU2006142322/15A patent/RU2396943C2/ru active Protection Beyond IP Right Term
- 2005-04-29 CA CA2563760A patent/CA2563760C/en not_active Expired - Lifetime
2006
- 2006-10-16 IL IL178651A patent/IL178651A/en active IP Right Review Request
- 2006-10-27 MX MX2012008068A patent/MX341426B/es unknown
- 2006-11-10 ZA ZA2006/09350A patent/ZA200609350B/en unknown
- 2006-11-29 NO NO20065502A patent/NO20065502L/no not_active Application Discontinuation
2011
- 2011-02-09 AU AU2011200543A patent/AU2011200543B2/en not_active Expired
- 2011-11-08 JP JP2011244443A patent/JP5124718B2/ja not_active Expired - Lifetime
2012
- 2012-08-13 CY CY20121100722T patent/CY1113069T1/el unknown
- 2012-12-10 IL IL223545A patent/IL223545A/en active IP Right Grant
2013
- 2013-03-13 HU HUS1300006C patent/HUS1300006I1/hu unknown
- 2013-03-27 LU LU92176C patent/LU92176I2/fr unknown
- 2013-03-29 CY CY2013012C patent/CY2013012I2/el unknown
2014
- 2014-03-07 LU LU92392C patent/LU92392I2/xx unknown
- 2014-03-19 CY CY2014015C patent/CY2014015I1/el unknown
2015
- 2015-08-27 CY CY20151100754T patent/CY1116655T1/el unknown
- 2015-12-18 LT LTPA2015053C patent/LTC2422766I2/lt unknown
- 2015-12-21 HU HUS1500073C patent/HUS1500073I1/hu unknown
- 2015-12-21 HU HUS1500072C patent/HUS1500072I1/hu unknown
- 2015-12-23 CY CY2015059C patent/CY2015059I1/el unknown
- 2015-12-23 CY CY2015060C patent/CY2015060I1/el unknown

Also Published As

Publication number	Publication date
BRPI0510500B8 (pt)	2021-05-25
IL223545A (en)	2016-04-21
ES2546982T3 (es)	2015-09-30
LU92176I2 (fr)	2013-05-27
CN102008453A (zh)	2011-04-13
IL178651A (en)	2012-12-31
RU2006142322A (ru)	2008-06-20
PT2422766E (pt)	2015-10-12
AU2005237266B2 (en)	2010-11-11
EP2422767A2 (en)	2012-02-29
EP1755555A2 (en)	2007-02-28
LU92176I9 (da)	2019-01-04
CY2014015I2 (el)	2015-12-09
SG152292A1 (en)	2009-05-29
CN107252423A (zh)	2017-10-17
EP2422766B1 (en)	2015-06-24
IL178651A0 (en)	2007-02-11
US20080063719A1 (en)	2008-03-13
SG10201605001SA (en)	2016-08-30
AU2011200543B2 (en)	2012-11-29
MX341426B (es)	2016-08-18
ZA200609350B (en)	2008-04-30
EP2422767A3 (en)	2012-04-25
HUS1500073I1 (hu)	2016-02-29
NZ550479A (en)	2009-11-27
PL1755555T3 (pl)	2012-11-30
JP2007535522A (ja)	2007-12-06
JP5000483B2 (ja)	2012-08-15
HUE025463T2 (en)	2016-02-29
IL223545A0 (en)	2013-02-03
SI1755555T1 (sl)	2012-10-30
HUS1300006I1 (hu)	2016-07-28
PT1755555E (pt)	2012-08-17
SG186673A1 (en)	2013-01-30
AU2005237266A1 (en)	2005-11-10
CA2563760A1 (en)	2005-11-10
LTC2422766I2 (lt)	2020-02-10
WO2005105043A2 (en)	2005-11-10
RU2396943C2 (ru)	2010-08-20
PL2422766T3 (pl)	2015-11-30
SI2422766T1 (sl)	2015-10-30
AU2011200543A8 (en)	2011-03-31
WO2005105043A3 (en)	2006-05-04
CA2563760C (en)	2013-07-02
LU92392I2 (fr)	2015-11-02
GB0409703D0 (en)	2004-06-02
EP2422766A3 (en)	2012-04-25
CY1116655T1 (el)	2017-03-15
JP5124718B2 (ja)	2013-01-23
CY2013012I1 (el)	2015-08-05
HK1167334A1 (en)	2012-11-30
CY2015060I1 (el)	2020-05-29
DK1755555T3 (da)	2012-08-20
HUS1500072I1 (hu)	2016-02-29
BRPI0510500B1 (pt)	2019-04-24
JP2012031209A (ja)	2012-02-16
EP2422766A2 (en)	2012-02-29
CY2014015I1 (el)	2015-12-09
CY2015059I1 (el)	2020-05-29
KR20070033978A (ko)	2007-03-27
HK1095282A1 (en)	2007-05-04
AU2011200543A1 (en)	2011-03-03
EP1755555B1 (en)	2012-05-23
BRPI0510500A (pt)	2007-10-30
MXPA06012493A (es)	2007-01-29
NO20065502L (no)	2007-01-24
CY2013012I2 (el)	2015-08-05
CY1113069T1 (el)	2015-08-05
ES2388289T3 (es)	2012-10-11
KR101287919B1 (ko)	2013-07-18
CN1964700A (zh)	2007-05-16

Publication	Publication Date	Title
HUS1500072I1 (hu)	2016-02-29	Glikopirrolát és magnézium-sztearát száraz por kompozíciói
DK1937824T3 (da)	2013-04-02	Sammensætninger af tRNA og anvendelser deraf
IL186490A0 (en)	2008-01-20	Multicyclic compounds and methods of their use
EP1851335A4 (en)	2010-05-26	COMPOSITIONS AND METHODS FOR USE OF STANDARDIZED MIXTURES
IL184822A0 (en)	2007-12-03	Extended release formulation of levetiracetam
ZA200704902B (en)	2008-10-29	Compositions comprising azelastine and methods of use thereof
IL189795A0 (en)	2008-08-07	Isoindole-imide compounds and compositions comprising and methods of using the same
CY2012004I1 (el)	2015-10-07	Μεθοδοι χρησης συνθεσεων αμινοπυριδινης παρατεταμενης αποδeσμευσης
IS8597A (is)	2007-01-24	Samsetningar rísedrónats og aðferðir við notkun þess
DK2069467T3 (da)	2014-10-20	Adskillende sammensætninger og fremgangsmåder til anvendelse
IL185309A0 (en)	2008-02-09	Isoqunoline compounds and methods of use thereof
ZA200805711B (en)	2009-11-25	Solid biocidal compositions and methods of using the same
ZA200803748B (en)	2009-07-29	Nematicidal compositions and methods
EP1767612A4 (en)	2008-04-09	SOLID FUEL COMPOSITION AND SOLID SOAP
IL186606A0 (en)	2008-01-20	Compositions and uses of amooranin compounds
SI1768691T1 (sl)	2013-07-31	Ekvorin vsebujoči sestavki in postopki za uporabo le-teh
ZA200804681B (en)	2009-11-25	Inhibitors of C-Met and uses thereof
ZA200707529B (en)	2008-09-25	Pro-fragrance and pro-flavorant compositions
FR2865354B1 (fr)	2006-03-10	Composition alimentaire suppletive et utilisation
DK1680134T3 (da)	2014-07-14	Sammensætninger og anvendelser deraf
GB2423081B (en)	2009-03-18	Pro-fragrance and pro-flavorant compositions
GB0514423D0 (en)	2005-08-17	Novel compositions and compounds
IS7772A (is)	2006-09-24	Lyfjasamsetningar af ramipríli og píretaníði
ZA200710971B (en)	2009-07-29	Elasmobranch-repelling compounds and methods of use